| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.05. | Xeris Biopharma Holdings Inc reports results for the quarter ended in January - Earnings Summary | 1 | Reuters | ||
| 09.05. | Xeris Biopharma Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.05. | Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events | 60 | Business Wire | CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative... ► Artikel lesen | |
| 06.05. | Why Are Xeris Biopharma Shares Moving Monday? | 1 | Benzinga.com | ||
| 15.03. | Xeris Biopharma director buys $9,720 in company stock | 2 | Investing.com | ||
| 07.03. | Earnings call: Xeris Biopharma reports robust growth and strategic refinancing | 4 | Investing.com | ||
| 06.03. | Xeris Biopharma Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 4 | SEC Filings | ||
| 06.03. | Xeris Biopharma Holdings, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
| 06.03. | Xeris Biopharma Holdings Inc reports results for the quarter ended in December - Earnings Summary | 5 | Reuters | ||
| 06.03. | Xeris Biopharma Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 06.03. | Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events | 151 | Business Wire | CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative... ► Artikel lesen | |
| 05.03. | Earnings Outlook For Xeris Biopharma Holdings | 3 | Benzinga.com | ||
| 10.01. | Why Is Xeris Biopharma (XERS) Stock Up 12% Today? | 5 | InvestorPlace | ||
| 10.01. | Amgen in pact with Xeris Biopharma for Tepezza injectable | 9 | Seeking Alpha | ||
| 04.01. | Xeris Biopharma sees FY revenue at higher end of guidance | 4 | Seeking Alpha | ||
| 04.01. | Xeris Biopharma Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.01. | Xeris Biopharma Updates Its Outlook for 2023 | 543 | Business Wire | CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 6.679 |
| GAMESTOP | 4.305 |
| NVIDIA | 4.244 |
| EVOTEC | 3.880 |
| TUI | 2.734 |
| BAYER | 2.104 |
| PLUG POWER | 1.748 |
| BIONTECH | 1.456 |
| RHEINMETALL | 1.441 |
| VOLKSWAGEN | 1.310 |
| SUPER MICRO COMPUTER | 1.223 |
| DEUTSCHE LUFTHANSA | 1.181 |
| AIXTRON SE | 1.109 |
| SIEMENS ENERGY | 1.090 |
| BYD | 1.001 |
| MERCEDES-BENZ | 966 |
| RWE | 910 |
| COMMERZBANK | 901 |
| HEIDELBERGER DRUCK | 843 |
| TESLA | 825 |
| DEUTSCHE BANK | 799 |
| RENK GROUP | 798 |
| NORDEX | 727 |
| BASF | 721 |
| JINKOSOLAR | 718 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
